Aug 2026 $5 M Private placement after listing $2 to $10 million 1
Intelligent Bio Solutions Inc.: Private sale, Aug 2026 × Investors in this round 1 investor had bought by the notice of Sep 14, 2026: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Intelligent Bio Solutions Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $399,999
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry Simeonidis · Executive Officer · Chief Executive Officer Spiro Sakiris · Executive Officer · Chief Financial Officer Jason Isenberg · Director · Director Jonathan Hurd · Director · Director Nicola Fraser · Director · Director Steven Boyages · Director · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New York Sold in IL Remarks in the notice On fees: “Ladenburg received $399,999.83 in commission, a $49,999.98 management fee, $60,000 expense reimbursement, and warrants for 101,832 shares of common stock. Ladenburg also receives 9% commission on gross proceeds from Series N-1 and N-2 Warrant exercises.”On the amounts: “Offering closed September 2, 2026”Signed by Spiro Sakiris, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 14, 2026. Read the notice at the SEC .
equity, options SEC Dec 2025 $10 M Private placement after listing $2 to $10 million 2
Intelligent Bio Solutions Inc.: Private sale, Dec 2025 × Investors in this round 2 investors had bought by the notice of Jan 13, 2026: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Intelligent Bio Solutions Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $899,999
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry Simeonidis · Executive Officer · Chief Executive Officer Spiro Sakiris · Executive Officer · Chief Financial Officer Jason Isenberg · Director Jonathan Hurd · Director Nicola Fraser · Director Steven Boyages · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New York Sold in IL, NY Remarks in the notice On fees: “Ladenburg also received reimbursement of expenses of $65,000 and will receive a cash fee equal to 9.0% of the gross proceeds received by the Company from the cash exercise of any Series K-1 Warrants and Series K-2 Warrants.”On the amounts: “The offering closed on January 2, 2026.”Signed by Spiro Sakiris, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 13, 2026. Read the notice at the SEC .
equity, options SEC Jul 2025 $4 M Private placement after listing $2 to $10 million 7
Intelligent Bio Solutions Inc.: Private sale, Jul 2025 × Investors in this round 7 investors had bought by the notice of Aug 11, 2025: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Intelligent Bio Solutions Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $345,542
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry Simeonidis · Executive Officer · Chief Executive Officer Spiro Sakiris · Executive Officer · Chief Financial Officer Jason Isenberg · Director Jonathan Hurd · Director Nicola Fraser · Director Steven Boyages · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ladenburg Thalmann & Co. Inc. (CRD 000000505) · New York, New York Sold in IL, NV, NY, PA, TX Remarks in the notice On fees: “In addition to the cash fees, the placement agent also received warrants to purchase 101,160 shares of common stock at an exercise price of $2.375 per share.”On the amounts: “Proceeds from warrant exercises & pre-payments per Inducement Ltr. Agmts. Series J Warrants for up to 4,046,456 shares issued in private placement. Up to $7,688,266 from future J Warrant exercises (if any) excluded; exercisable after stockholder approval.”Signed by Spiro Sakiris, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 11, 2025. Read the notice at the SEC .
options SEC Mar 2024 $10 M Private placement after listing $10 to $50 million 8
Intelligent Bio Solutions Inc.: Private sale, Mar 2024 × Investors in this round 8 investors had bought by the notice of Mar 22, 2024: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Intelligent Bio Solutions Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken $10,000
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $910,455
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harry Simeonidis · Executive Officer · Chief Executive Officer Spiro Sakiris · Executive Officer · Chief Financial Officer Christopher Towers · Director Jason Isenberg · Director Jonathan Hurd · Director Lawrence Fisher · Director Steven Boyages · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New York Sold in CA, CT, FL, IL, MA, MD, MN, NJ, NY, TX Remarks in the notice On fees: “Ladenburg also received common stock warrants for 5% of shares and pre-funded warrants sold (exercise price of 125% of offering price per share & expiration of 5 yrs. from issuance) and reimbursement expenses of $65,000.”On the amounts: “The offering closed on March 12, 2024.”Signed by Spiro Sakiris, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 22, 2024. Read the notice at the SEC .
equity, options SEC